Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that examining the scalp closely and checking for iron levels and thyroid issues is key to understanding chronic hair loss in women.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Computer-aided imaging system helps measure balding area in female pattern hair loss.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

The study concluded that certain areas of the scalp and beard are safe for hair transplant donor sites in Indian men.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Using scalp stem cells can improve hair transplants.

Antibody treatments show promise for hair loss but need more research.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Finasteride effectively treats frontal hair loss with few side effects.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

The conclusion is that bilateral lateral scalp reduction has a high risk of severe complications, leading doctors to stop using it.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

The boy with woolly hair nevus had thinner hair and abnormal hair follicles, which improved with treatment but worsened when treatment stopped.

Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.

A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.

Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Scalp lifting surgery can safely and effectively reduce baldness if done with careful planning and proper technique.

Surgical hair restoration has improved since 1959, with new techniques like minigrafts, micrografts, and scalp reductions creating more natural hairlines and reducing bald skin, despite some risks and potential for scarring.

Trichoscopy is reliable for diagnosing different types of frontal non-scarring hair loss.

Genetic hair shaft abnormalities can be seen with microscopes and often affect scalp hair.

New hair restoration techniques look more natural, increasing their popularity.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Cellcurin therapy with microneedling increases hair density and thickness in treating hair loss in men and women.

Trichoscopy is effective for diagnosing and monitoring female pattern hair loss.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.